V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003541 | 310011441 | null | 64.9 | Adjuvant (A) | 2014-06-24 | 2014-07-19 | Trial Unspecified | N | N | 310018158 | TRIAL |
| 310003542 | 310011663 | 1.78 | 49 | Palliative (P) | 2014-11-01 | 2014-11-01 | CHEMO-T TRIAL | Y | N | 310018159 | TRIAL |
| 310003543 | 310011663 | 1.65 | null | Palliative (P) | 2014-04-12 | 2014-04-24 | DOXORUBICIN | N | N | 310018159 | DOXORUBICIN |
| 310003544 | 310011663 | 1.93 | null | Curative (C) | 2015-12-13 | 2015-12-14 | CHOP R - 21 days | 2 | N | 310018159 | CHOP R |
| 310003545 | 310011917 | 1.58 | 55 | Neo-adjuvant (N) | 2017-06-22 | 2017-06-22 | CISPLATIN + GEMCITABINE | 2 | N | 310018165 | CISPLATIN + GEMCITABINE |
| 310003546 | 310011917 | 1.83 | 92.5 | Adjuvant (A) | 2016-02-20 | 2016-02-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310018165 | CISPLATIN + GEMCITABINE |
| 310003547 | 310001484 | null | 63 | null | 2013-12-02 | 2013-12-02 | CHOP R - 21 days | 2 | N | 310018169 | CHOP R |
| 310003548 | 310006638 | 1.63 | 67.2 | Palliative (P) | 2017-05-18 | 2017-05-19 | CISPLATIN + GEMCITABINE | 02 | N | 310018173 | CISPLATIN + GEMCITABINE |
| 310003549 | 310006638 | 1.88 | 91.9 | Palliative (P) | 2013-03-12 | 2013-03-12 | CISPLATIN + GEMCITABINE | Y | null | 310018173 | CISPLATIN + GEMCITABINE |
| 310003550 | 310001485 | 1.63 | null | Palliative (P) | 2015-09-29 | 2015-10-13 | Carboplatin + Etoposide iv&po | N | N | 310018176 | CARBOPLATIN + ETOPOSIDE |
| 310003551 | 310001486 | 1.73 | null | Palliative (P) | 2015-06-01 | 2015-06-01 | Ipilimumab | N | N | 310018180 | IPILIMUMAB |
| 310003552 | 310001487 | 1.65 | 82 | Curative (C) | 2014-04-24 | 2014-04-24 | Cisplatin 7 day | N | Y | 310018182 | CISPLATIN |
| 310003554 | 310006639 | 1.67 | null | Curative (C) | 2014-01-09 | 2014-01-29 | Cisplatin 7 day | N | N | 310018187 | CISPLATIN |
| 310003555 | 310001489 | 1.56 | 84.9 | Palliative (P) | 2015-11-18 | 2015-11-21 | Carboplatin + Etoposide iv&po | N | N | 310018189 | CARBOPLATIN + ETOPOSIDE |
| 310003556 | 310006640 | 1.66 | 85.2 | Palliative (P) | 2017-05-02 | 2017-05-05 | Trial Unspecified | 02 | N | 310018191 | TRIAL |
| 310003557 | 310009069 | null | null | Curative (C) | 2016-12-10 | 2016-12-17 | CHOP R - 21 days | N | N | 310018192 | CHOP R |
| 310003558 | 310009069 | null | 89.6 | Palliative (P) | 2017-11-03 | 2017-11-06 | Trial Unspecified | 01 | N | 310018192 | TRIAL |
| 310003559 | 310001490 | 1.77 | 114.6 | Curative (C) | 2013-11-19 | 2013-11-19 | Cisplatin | 02 | N | 310018200 | CISPLATIN |
| 310003560 | 310001490 | null | 82.5 | Palliative (P) | 2015-11-07 | 2015-11-07 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310018200 | CISPLATIN + GEMCITABINE |
| 310003561 | 310001490 | 1.54 | 87 | Palliative (P) | null | 2013-12-24 | PEMBROLIZUMAB | 02 | N | 310018200 | PEMBROLIZUMAB |
| 310003562 | 310001491 | 1.73 | 85.2 | null | 2017-03-11 | 2017-03-12 | Ipilimumab | 02 | N | 310018203 | IPILIMUMAB |
| 310003563 | 310001492 | 1.74 | 85.2 | Palliative (P) | 2014-03-25 | 2014-03-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310018204 | CISPLATIN + GEMCITABINE |
| 310003564 | 310001493 | 1.61 | 91.5 | Curative (C) | 2016-02-26 | 2016-03-05 | Cisplatin | N | N | 310018205 | CISPLATIN |
| 310003565 | 310001493 | 1.61 | 99.1 | Curative (C) | null | 2015-12-09 | CHOP R - 21 days | N | null | 310018205 | CHOP R |
| 310003566 | 310001493 | 1.67 | 55.9 | Disease modification (D) | 2015-01-29 | 2015-01-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310018205 | CISPLATIN + GEMCITABINE |
| 310003567 | 310001493 | 1.7 | 81.2 | Palliative (P) | 2017-10-20 | 2017-10-21 | Carboplatin + Etoposide iv&po | N | N | 310018205 | CARBOPLATIN + ETOPOSIDE |
| 310003568 | 310001493 | 1.62 | 78.4 | null | 2015-05-27 | 2015-05-31 | Doxorubicin 75mg/m2 | 02 | N | 310018205 | DOXORUBICIN |
| 310003569 | 310001493 | 1.83 | 84.7 | Palliative (P) | 2014-10-10 | 2014-10-11 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310018205 | CISPLATIN + GEMCITABINE |
| 310003570 | 310001493 | 1.62 | 114.1 | Palliative (P) | 2016-07-15 | 2016-07-29 | Doxorubicin 75mg/m2 | N | N | 310018205 | DOXORUBICIN |
| 310003571 | 310001494 | 1.62 | 77.4 | Palliative (P) | 2016-02-17 | 2016-02-20 | Carboplatin + Etoposide iv&po | 02 | N | 310018218 | CARBOPLATIN + ETOPOSIDE |
| 310003572 | 310001495 | 1.72 | 113.8 | Curative (C) | 2015-09-05 | 2015-09-27 | CHOP R - 21 days | N | N | 310018220 | CHOP R |
| 310003573 | 310001495 | 1.78 | 74.65 | Palliative (P) | 2017-07-02 | 2017-07-07 | Carboplatin + Etoposide iv&po | null | null | 310018220 | CARBOPLATIN + ETOPOSIDE |
| 310003574 | 310001496 | 1.69 | 99 | Palliative (P) | 2017-02-05 | 2017-02-23 | DOXORUBICIN | 02 | N | 310018222 | DOXORUBICIN |
| 310003575 | 310001497 | 1.69 | 84.2 | Curative (C) | null | 2013-09-21 | Trial Unspecified | 1 | null | 310018228 | TRIAL |
| 310003576 | 310001497 | 1.83 | 88.3 | null | 2014-10-17 | 2014-10-30 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310018228 | CISPLATIN + GEMCITABINE |
| 310003577 | 310001498 | 1.74 | 88.2 | Palliative (P) | 2017-10-23 | 2017-11-06 | CARBOPLATIN + ETOPOSIDE | N | N | 310018236 | CARBOPLATIN + ETOPOSIDE |
| 310003578 | 310001499 | 1.83 | 76.5 | Palliative (P) | 2017-07-20 | 2017-08-07 | Ipilimumab | 02 | N | 310018237 | IPILIMUMAB |
| 310003579 | 310001499 | 1.69 | 4.2 | Palliative (P) | 2014-10-20 | 2014-10-28 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310018237 | CISPLATIN + GEMCITABINE |
| 310003580 | 310001499 | 1.8 | 96 | Palliative (P) | 2013-02-14 | 2013-02-22 | Carboplatin + Etoposide iv&po | 02 | null | 310018237 | CARBOPLATIN + ETOPOSIDE |
| 310003581 | 310010345 | 1.63 | null | Curative (C) | null | 2015-03-14 | CHEMO-T TRIAL | N | N | 310018244 | TRIAL |
| 310003582 | 310010345 | null | 10.6 | Palliative (P) | 2014-09-30 | 2014-10-01 | Ipilimumab | 02 | N | 310018244 | IPILIMUMAB |
| 310003583 | 310010345 | 1.8 | 68.1 | Curative (C) | 2015-10-27 | 2015-11-23 | Cisplatin | 02 | N | 310018244 | CISPLATIN |
| 310003584 | 310011665 | 1.62 | 61.5 | Palliative (P) | 2015-05-24 | 2015-05-24 | Ipilimumab | 2 | N | 310018249 | IPILIMUMAB |
| 310003585 | 310011665 | 1.86 | 82.3 | null | 2018-01-18 | 2018-02-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310018249 | CISPLATIN + GEMCITABINE |
| 310003586 | 310001500 | 1.78 | 70.5 | Palliative (P) | 2013-05-21 | 2013-05-23 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310018252 | CISPLATIN + GEMCITABINE |
| 310003587 | 310001500 | null | 88 | Curative (C) | 2015-03-16 | 2015-04-04 | CHOP R - 21 days | 02 | N | 310018252 | CHOP R |
| 310003588 | 310001500 | 1.73 | 67.6 | Palliative (P) | 2014-04-11 | 2014-04-14 | PEMBROLIZUMAB | 02 | N | 310018252 | PEMBROLIZUMAB |
| 310003591 | 310001502 | 1.53 | 90.6 | Adjuvant (A) | 2017-06-24 | 2017-07-01 | Cisplatin+Gemcitabine (gallbladder) | N | N | 310018259 | CISPLATIN + GEMCITABINE |
| 310003592 | 310006647 | 1.64 | 62 | Palliative (P) | 2016-02-22 | 2016-02-29 | Ipilimumab | 02 | N | 310018261 | IPILIMUMAB |
| 310003593 | 310006647 | 1.71 | null | Palliative (P) | null | 2017-03-02 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 310018261 | CISPLATIN + GEMCITABINE |